Edwards Lifesciences (EW) Profit After Tax (2009 - 2026)

Edwards Lifesciences' Profit After Tax history runs 18 years deep, the most recent figure standing at $380.7 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 4.7% year-over-year to $380.7 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 73.89% YoY), while the FY2025 annual figure was $1.1 billion, down 23.4% from the prior year.
• Profit After Tax was $380.7 million for Q1 2026 at Edwards Lifesciences, up from $87.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $3.1 billion in Q3 2024 to a low of $87.1 million in Q4 2025.
• Historically, Profit After Tax has averaged $489.1 million across 5 years, with a median of $351.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax jumped 700.31% in 2024, then slumped 90.46% in 2025.
• A 5-year view of Profit After Tax shows it stood at $200.5 million in 2022, then surged by 66.13% to $333.1 million in 2023, then rose by 15.37% to $384.3 million in 2024, then sank by 77.34% to $87.1 million in 2025, then jumped by 337.08% to $380.7 million in 2026.
• The last three Profit After Tax figures came in at $380.7 million (Q1 2026), $87.1 million (Q4 2025), and $293.1 million (Q3 2025), per Business Quant data.